|
|
|
Insider
Information: |
Winningham Rick E |
Relationship: |
|
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,686,408 |
|
Indirect Shares
|
96,467 |
|
|
Direct
Value |
$32,096,465 |
|
|
Indirect Value
|
$926,083 |
|
|
Total
Shares |
2,782,875 |
|
|
Total
Value |
$33,022,548 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-15.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Innoviva Inc |
INVA |
Director |
2014-08-15 |
825,391 |
2008-01-29 |
0 |
Premium* |
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
10,444 |
2012-01-11 |
0 |
Premium* |
|
Theravance Biopharma, Inc. |
TBPH |
|
2024-04-02 |
1,850,573 |
2024-04-02 |
96,467 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
130 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2008-03-11 |
4 |
B |
$10.40 |
$209,421 |
D/D |
20,000 |
43,118 |
2.81 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2012-02-20 |
4 |
D |
$18.54 |
$396,496 |
D/D |
(21,386) |
469,302 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2013-09-12 |
4 |
AS |
$40.03 |
$894,791 |
D/D |
(22,353) |
690,106 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
|
2022-02-18 |
4 |
D |
$9.61 |
$218,243 |
D/D |
(22,710) |
1,279,300 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2008-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
23,118 |
23,118 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2010-10-26 |
4 |
A |
$0.00 |
$0 |
D/D |
27,500 |
186,878 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2014-04-17 |
4 |
AS |
$140.00 |
$3,850,000 |
D/D |
(27,500) |
13,587 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2017-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
903,399 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
894,377 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2017-02-20 |
4 |
D |
$33.78 |
$1,123,658 |
D/D |
(33,264) |
870,135 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
|
2024-02-20 |
4 |
D |
$8.92 |
$331,788 |
D/D |
(37,196) |
1,558,769 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
|
2023-02-20 |
4 |
D |
$10.44 |
$390,665 |
D/D |
(37,420) |
1,313,377 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2012-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
37,657 |
37,657 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2012-01-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(37,657) |
0 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
CHIEF EXECUTIVE OFFICER |
|
2022-12-14 |
4 |
S |
$11.19 |
$559,500 |
D/D |
(50,000) |
1,350,797 |
0 |
% |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2014-05-09 |
4 |
D |
$26.86 |
$1,349,044 |
D/D |
(50,225) |
703,038 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-05-10 |
4 |
AS |
$26.41 |
$1,443,201 |
D/D |
(54,646) |
559,006 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2010-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
169,040 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2012-01-11 |
4 |
OE |
$8.23 |
$842,950 |
D/D |
55,000 |
46,656 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2014-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
62,403 |
921,641 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2015-08-14 |
4 |
B |
$11.79 |
$744,421 |
D/D |
63,140 |
583,298 |
2.81 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2012-05-04 |
4 |
OE |
$3.10 |
$400,070 |
D/D |
63,225 |
532,527 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-03-01 |
4 |
AS |
$22.53 |
$1,439,059 |
D/D |
(63,873) |
613,652 |
0 |
- |
|
INVA |
Innoviva Inc |
Chief Executive Officer |
|
2011-02-28 |
4 |
AS |
$22.49 |
$1,544,030 |
D/D |
(67,000) |
677,525 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2018-05-20 |
4 |
D |
$24.31 |
$1,643,769 |
D/D |
(67,617) |
919,620 |
0 |
- |
|
130 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|